GO
Loading...

Quest Diagnostics Inc

More

  • doctor

    It appears that Washington is about to enact sweeping legislation that will be the greatest shift in public policy in decades. Yes, we can bemoan the lack of a completely private enterprise driven system but the reality is Big Brother is here and he's not going away. Without a doubt there will be implications for investors that need to be considered; and it's not all bad news from an investment perspective.

  • Lightning Round OT: Dynegy, Quest Diagnostics and More Wednesday, 7 Oct 2009 | 7:25 PM ET
    MM_promo_Cramerica_Challenge_530x50.jpg

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • Halftime Report: Are The Bulls Back? Friday, 4 Sep 2009 | 1:18 PM ET

    Considering investors stepped into this market and bid shares higher even with unemployment at a 26-year high, is it safe to assume the bulls are back?

  • Lightning Round OT: Merck, Dell and More Monday, 17 Aug 2009 | 9:11 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • Pee Is For Pharma, Pfizer & Profits Monday, 10 Aug 2009 | 3:02 PM ET
    Pharma Stocks

    Critics have been saying for years that big pharma's been pi..., er, throwing away money on relatively unproductive research and development of new drugs. But a new study shows urine could eventually provide a new revenue stream.

  • Labs Under Pressure Tuesday, 28 Jul 2009 | 3:58 PM ET

    Companies that provide laboratory services are down late in the day on talk that the the new Senate Finance Committee bill on healthcare will contain a co-pay for labs that will save some $20 billion over 10 years, which may put pressure on profits of those companies.

  • Trading the Cap-and-Trade Bill Wednesday, 8 Jul 2009 | 6:52 PM ET

    Washington has doubly blessed this motor maker, Cramer says.

  • Cramer: The Market’s New Leader? Tuesday, 7 Jul 2009 | 9:38 PM ET

    This sector offers long-term growth, even in a slowdown. Even oil can’t promise that.

  • Cramer: 3 Obama-Blessed Health-Care Picks Tuesday, 7 Jul 2009 | 3:43 PM ET

    Plus, the Mad Money host reacts to the Justice Department's probe into telecom.

  • Signs Of A "Dope-pression" Wednesday, 6 May 2009 | 3:18 PM ET
    Wuest Diagnostics

    Talk about a silver lining! Quest Diagnostics reports that US workers are not using as much cocaine. Or meth.

  • Market Insider: Tuesday Look Ahead Monday, 20 Apr 2009 | 9:40 PM ET

    Markets are bracing for a landslide of earnings news Tuesday and more focus on the Treasury's bank bailout plans.

  • Jobs Breakdown by Sector Wednesday, 18 Mar 2009 | 9:41 PM ET

    Here is a breakdown of where the jobs are right now by sector. See what companies are hiring what types of jobs and in which states. Click through to see all major sectors.

  • Charts Point to 15 Growth Stocks Friday, 27 Feb 2009 | 6:13 PM ET

    Amid the gloom, Birinyi Associates' Cleve Rueckert found what he sees as a bright spot in the stock market. In a note, he says growth is the place to be, based on performance of the S&P's Pure Growth Index versus the S&P Pure Value Index. Here's his list of 15 stocks in the S&P 500 that fit three key growth criteria.

  • Lightning Round: Aetna, Weyerhauser and More Monday, 17 Nov 2008 | 9:04 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Lightning Round: Airgas, Statoil and More Monday, 14 Jul 2008 | 7:27 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Pops & Drops: Quest Diagnostics, Sears... Monday, 21 Apr 2008 | 6:48 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Quest Diagnostics and Jeffries Group popped while Sears and National City dropped.

  • On the Line: Pepsico CEO Indra Nooyi Tuesday, 24 Jul 2007 | 8:08 PM ET

    If the signs are right, the market could be slowing. In her first ever appearance on CNBC, the beverage giant chief executive explains why her stock is one of the best to own right now.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Recent spikes in Quest Diagnostics's stock price suggest the No. 1 medical testing company could be the latest buyout target in health care, but its valuation and debt load may keep private equity bidders at bay.

  • Thirteen Stocks On The Radar Friday, 1 Jun 2007 | 4:21 PM ET

    Retail investors looking to jump back into the stock market may find it difficult to find out where to even begin given the wealth of mutual funds and ETFs out there.  And even those comfortable with fund-based portfolios may want to explore the field of individual stocks, which are riskier than fund but also potentially more rewarding.

  • Sudden Death Monday, 30 Apr 2007 | 7:02 PM ET

    There goes swifty! Quest Diagnostics, Cepheid and Terra Nitrogen for a buzzer-beater.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.